PEPTIDE CORPUS

Tissue Repair & Regeneration

Palmitoyl Tetrapeptide-7

Space-filling model of Palmitoyl Tetrapeptide-7

Most anti-ageing peptides argue about collagen. Palmitoyl tetrapeptide-7 argues about inflammation: the case for it is that it lowers interleukin-6, the messenger skin cells release after ultraviolet exposure, which would blunt one of the routes by which sun damages skin over years. It is best known as half of Matrixyl 3000 and is almost always sold blended with palmitoyl tripeptide-1. The clean test has never been run, and this record names the gaps rather than glossing them: no study on file isolated the ingredient from its blend, no randomised trial of it exists, and the concentration figures on ingredient lists come from suppliers rather than from any trial that varied the dose.

Last updated

Studied forInflammatory response research · Photoageing context · Dermal-epidermal junction support
Evidence on file1 randomised human trial · 1 human observational study · 1 animal study · 1 citation not yet graded
Strongest sourceComprehensive evaluation of the efficacy and safety of a new multi-component anti-aging topical eye cream (randomised human trial)

Mechanism

Reduces interleukin-6 secretion by skin cells after UVB exposure, and is associated with laminin and collagen VII synthesis.

Reported effects

What sources associate with this compound. Reported categories, not outcomes we have graded — each would need its own citation and rung.

  • Inflammatory response research
  • Photoageing context
  • Dermal-epidermal junction support

Manufacturer’s claim vendor marketing

For a proprietary cosmetic ingredient the manufacturer is the originator — there is no upstream to defer to, and this is often the only description that exists. It is reproduced as an attributed claim, with the label its source gave it. It is not graded and it is not evidence — the graded studies are under Literature.

Vendor claims quoted from fetched page: "collagen-boosting properties that target wrinkles and fine lines"; "restore the skin's firmness and elasticity by supporting the skin's structural components"; "reduce fine lines, wrinkles, and sagging skin by promoting collagen production". No n= or study duration given on fetched page.

Manufacturer
Croda (Sederma brand)
Sold as
Matrixyl 3000 (blend with Palmitoyl Tripeptide-1); also ActiTide 3000 (Uniproma), Haloxyl (distributed by Brenntag)
Manufacturer’s recommended use
Vendor claim: "generally used in concentrations of 2% to 5% in formulations"

Source page — nofollow, because a vendor link is a reference here, not an endorsement.

Dosing on file unverified

0.1-0.5% in creams, 1-2x/day

Carried from a source that labels it unverified, and reproduced with that label attached. A record of what is reported, not a recommendation. No citation on this page establishes it.

Literature on file 4

Not graded

1 citation whose study design could not be read from the title. Left ungraded rather than guessed at.

Identity

PubChem CID 10078408 computed 3D conformer Space-filling 3D model of Palmitoyl Tetrapeptide-7, carbon grey, nitrogen blue, oxygen red
Built from the SMILES on this record — the atoms and bonds are exact. The shape is one computed low-energy pose, not a measured structure: a flexible peptide in solution has no single conformation, and where the SMILES leaves a stereocentre undefined the pose commits to one arbitrarily. The skeletal formula below claims connectivity and nothing more, which is what we actually know.
Skeletal formulathe canonical depiction
2D chemical structure of Palmitoyl Tetrapeptide-7

Drawn by PubChem from CID 10078408, the identifier on this record.

Molecular weight
694.9
Molecular formula
C34H62N8O7
CAS number
221227-05-0
PubChem CID
10078408
InChI key
IHRKJQSLKLYWBQ-QKDODKLFSA-N
SMILES
CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)O
InChI
InChI=1S/C34H62N8O7/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-19-29(44)39-24-30(45)40-25(20-21-28(35)43)32(47)42-23-16-18-27(42)31(46)41-26(33(48)49)17-15-22-38-34(36)37/h25-27H,2-24H2,1H3,(H2,35,43)(H,39,44)(H,40,45)(H,41,46)(H,48,49)(H4,36,37,38)/t25-,26-,27-/m0/s1

Also called

  • ActiTide 3000
  • Matrixyl 3000
  • Palmitoyl Tetrapeptide-7

Notes unverified prose

12-week clinical trial: skin hydration +28.12%, elasticity +18.81%, collagen +54.99%; Matrixyl 3000 blend; Phase 4; NCT05932732; Clinical trials in JCAD

Not on file 5

1 of the 8 fields we track hold nothing on this record, and each says why. 4 further absences are named below. A blank field is a bug; a named absence is a finding.

  • amino-acid sequencenothing we hold supplies it
  • half-lifenothing we hold supplies it
  • single agent evidenceevery human record on file tested palmitoyl tetrapeptide-7 inside a blend or a finished formulation; no study isolated it
  • randomised human trialno randomised trial of this ingredient is on file
  • effect size by concentrationthe 0.1-0.5% and 2-5% use figures on file come from suppliers, not from a trial that varied concentration

Each field links to every other record missing the same thing. The full ledger holds 765 gaps across 163 records.

Listed prices 5

What 5 shops we track listed for Palmitoyl Tetrapeptide-7, read from their own public catalogues on 2026-09-14. We take no commission on these and they are not ranked by any payment — how vendors are scored.

Compare prices5 listings from 5 shops
Listed in USD
VendorSizePricePer mg
Raw Amino 200 mg $184.00 USD $0.92/mg
Core Peptides 200 mg $197.00 USD $0.98/mg
USA Peptide Sciences 200 mg $200.00 USD $1.00/mg
Listed in CAD
VendorSizePricePer mg
Peptide Shop Canada 200 mg $123.30 CAD $0.62/mg
Core Peptides Canada 200 mg $242.90 CAD $1.21/mg

Prices are the vendor's own listing, reproduced with the date we read it — never converted between currencies, and compared per milligram only where the vendor states the vial size.

Share this record

Share card for Palmitoyl Tetrapeptide-7: structure, evidence rung and sources on file
www.peptidecorpus.com/peptides/palmitoyl-tetrapeptide-7